Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.

Background: Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication. The ideal retreatment regimen remains unclear, especially in developing countries, where the infection presents high prevalence and resistance to antibiotics. T...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Gastroenterology Vol. 9; pp. 38 - 39
Autores principales: Eisig JN, Silva FM, Barbuti RC, Rodriguez TN, Malfertheiner P, Moraes Filho JP, Zaterka S, Eisig, Jaime N, Silva, Fernando M, Barbuti, Ricardo C, Rodriguez, Tomás Navarro, Malfertheiner, Peter, Moraes Filho, Joaquim P P, Zaterka, Schlioma
Formato: clinical trial research Journal Article
Publicado: BioMed Central 2009
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105354343&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105354343
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1471230X
        1CHO
      jtl: BMC Gastroenterology
      issn: 1471230X
      maglogo: N
    pubinfo:
      dt: 2009
      vid: 9
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        105354343
        NLM19470177
        2010312496
        10.1186/1471-230X-9-38
        NLM19470177
        105354343
      ppf: 38
      ppct: 1
      formats:
      tig:
        atl: Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.
      aug:
        au:
          Eisig JN
          Silva FM
          Barbuti RC
          Rodriguez TN
          Malfertheiner P
          Moraes Filho JP
          Zaterka S
          Eisig, Jaime N
          Silva, Fernando M
          Barbuti, Ricardo C
          Rodriguez, Tomás Navarro
          Malfertheiner, Peter
          Moraes Filho, Joaquim P P
          Zaterka, Schlioma
        affil: Serviço de Gastroenterologia Clínica, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil
      sug:
        subj:
          Antiinfective Agents Therapeutic Use
          Helicobacter Infections Drug Therapy
          Helicobacter Pylori
          Nitrofurans Therapeutic Use
          Ofloxacin Therapeutic Use
          Sulfur Compounds Therapeutic Use
          Adult
          Aged
          Antiinfective Agents Adverse Effects
          Clinical Trials
          Dose-Response Relationship, Drug
          Drug Resistance, Microbial
          Drug Therapy, Combination
          Female
          Male
          Middle Age
          Nitrofurans Adverse Effects
          Ofloxacin Adverse Effects
          Prospective Studies
          Salvage Therapy
          Sulfur Compounds Adverse Effects
          Treatment Outcomes
          Human
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background: Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication. The ideal retreatment regimen remains unclear, especially in developing countries, where the infection presents high prevalence and resistance to antibiotics. The study aimed at determining the efficacy, compliance and adverse effects of a regimen that included furazolidone, levofloxacin and lansoprazole in patients with persistent Helicobacter pylori infection, who had failed to respond to at least one prior eradication treatment regimen.Methods: This study included 48 patients with peptic ulcer disease. Helicobacter pylori infection was confirmed by a rapid urease test and histological examination of samples obtained from the antrum and corpus during endoscopy. The eradication therapy consisted of a 7-day twice daily oral administration of lansoprazole 30 mg, furazolidone 200 mg and levofloxacin 250 mg. Therapeutic success was confirmed by a negative rapid urease test, histological examination and 14C- urea breath test, performed 12 weeks after treatment completion. The Chi-square method was used for comparisons among eradication rates, previous treatments and previous furazolidone use.Results: Only one of the 48 patients failed to take all medications, which was due to adverse effects (vomiting). Per-protocol and intention-to-treat eradication rates were 89% (95% CI- 89%-99%) and 88% (88-92%), respectively. Mild and moderate adverse effects were reported by 41 patients (85%). For patients with one previous treatment failure, the eradication rate was 100%. Compared to furazolidone-naïve patients, eradication rates were lower in those who had failed prior furazolidone-containing regimen(s) (74% vs. 100%, p = 0.002).Conclusion: An empiric salvage-regimen including levofloxacin, furazolidone and lansoprazole is very effective in the eradication of Helicobacter pylori, particularly in patients that have failed one prior eradication therapy.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N